MarketCapExport financials
Fortress Biotech (FBIO)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Fortress Biotech Income Statement 2025-2006 | FBIO
Brief overview of revenue and earnings at Fortress Biotech
The comparison covers a five-year financial horizon. According to figures from Fortress Biotech, revenue changed from 45.6 million dollars to 63.3 million dollars over five years. The cumulative result was +38.7%, corresponding to roughly 6.8% per year. This represents moderate business growth.
At the gross-profit level, the result moved from $31 million to $42.3 million, a change of +36.6%. There was no major divergence between sales and cost of revenue. Gross margin moved from 68% to 66.9%. Gross profitability remained broadly stable.
EBITDA was −$88.9 million at the beginning and −$69.8 million at the end of the period (+21.5%). Changes in revenue did not translate into comparable EBITDA performance. The EBITDA share of revenue changed from −195.1% to −110.4%. The business generated more EBITDA from each unit of revenue.
Net income moved from −$46.5 million at the start to $37 million at the end. The business moved out of a loss and ended the period with a profit.
What the figures show
The results present an uneven picture without one dominant signal. The constructive conclusion rests on improving net profitability, a larger revenue base and higher operating efficiency. The main areas of concern are limited operating profitability and pressure from direct costs. Further direction will depend on top-line growth, operating profitability, and net income.
Annual Income Statement Fortress Biotech
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
77.8 M | 32.4 M | 16.2 M | 4.68 M | 171 M | 230 M | 130 M | 64.3 M | 167 M | 93.9 M | 117 M | 90.8 M | 82.5 M | 159 M | 48.8 M | - | - | - | - | - |
Shares |
27.9 M | 20.8 M | 8.11 M | 5.92 M | 81.7 M | 72 M | 54.7 M | 43.5 M | 41.7 M | 40 M | 47.1 M | 36.3 M | 30.4 M | 21.7 M | 7.66 M | 4.45 M | - | - | - | - |
Historical Prices |
2.79 | 1.56 | 2 | 0.79 | 2.09 | 3.19 | 2.25 | 2.07 | 3.96 | 2.45 | 2.48 | 2.5 | 2.72 | 7.34 | 6.33 | - | - | - | - | - |
Net Income |
37 M | 21 M | 31 M | -86.6 M | -64.7 M | -46.5 M | -40 M | -84.1 M | -66.9 M | -55.1 M | -48.4 M | -20.4 M | -37.2 M | -27.6 M | -36.4 M | -9.98 M | -3.67 M | -3.8 M | -2.64 M | -123 K |
Revenue |
63.3 M | 57.7 M | 84.5 M | 75.7 M | 68.8 M | 45.6 M | 36.6 M | 26.9 M | 188 M | 16.5 M | 863 K | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
20.9 M | 20.9 M | 22.9 M | 30.8 M | 32.1 M | 14.6 M | 10.5 M | 6.12 M | 3.66 M | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | 31 M | 26.1 M | 20.8 M | 26.4 M | 5.13 M | 863 K | - | - | - | - | - | - | - | - | - |
Operating Income |
-70.2 M | -110 M | -142 M | -204 M | -189 M | -94.3 M | -111 M | -120 M | -89.8 M | -65.7 M | -50.5 M | -20.7 M | -35.8 M | -27.2 M | -35 M | -9.24 M | -2.61 M | - | - | - |
Interest Expense |
17.6 M | 1.32 M | -3.4 M | 1.22 M | - | - | 11.8 K | 10.3 K | 5.86 M | 3.69 M | 1.48 M | 1.34 M | 1.92 M | 670 K | 74 K | 1.54 M | 1.05 M | - | - | - |
EBITDA |
-69.8 M | -109 M | -140 M | -200 M | -186 M | -88.9 M | -106 M | -118 M | -99.1 M | -65.2 M | -50.5 M | -20.6 M | -35.8 M | -27.2 M | -33.6 M | -9.24 M | -2.61 M | - | - | - |
Operating Expenses |
- | - | - | - | - | 125 M | 137 M | 141 M | 128 M | 70.8 M | 51.4 M | 20.7 M | 35.8 M | 27.2 M | 35 M | - | - | - | - | - |
General and Administrative Expenses |
96.4 M | 87.7 M | 91 M | 114 M | 86.8 M | - | 55.6 M | 53.4 M | 73 M | 35.2 M | 21.6 M | 10.4 M | 10.1 M | 8.66 M | - | 900 K | 343 K | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement Fortress Biotech
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
26.9 M | 31.5 M | - | 27.2 M | 26.9 M | 26.5 M | 27.9 M | 19.7 M | 18.3 M | 17.2 M | 15.1 M | 7.5 M | 7.38 M | 6.79 M | 7.37 M | 5.96 M | 88.7 M | 86.3 M | 101 M | 81.3 M | 81 M | 80.9 M | 94.9 M | 76.1 M | 68.6 M | 63.5 M | 74 M | 56.9 M | 53.7 M | 48.5 M | 57.8 M | 44.8 M | 43.4 M | 42.5 M | 51 M | 40.7 M | 40.6 M | 40.4 M | 48.9 M | 40.1 M | 39.9 M | 39.7 M | 47.1 M | 39.4 M | 39.1 M | 38.6 M | 46.5 M | 36 M | 36 M | 35.9 M | 39.7 M | 32.6 M | 28.1 M | 25.2 M | 24.4 M | 24.4 M | 19.2 M | 18.6 M | 18.6 M | 7.03 M | 5.85 M | 18.6 M |
Net Income |
13.4 M | 110 M | - | 5.85 M | 15.5 M | -10.6 M | - | -12.9 M | -10.9 M | -15.4 M | - | -5.04 M | -24.8 M | -21.5 M | - | -22.5 M | -21.4 M | -15.8 M | - | -20.8 M | -3.54 M | -8.82 M | - | -15.5 M | -13.3 M | -12.4 M | - | -12.8 M | -13.1 M | 1.39 M | -24.9 M | -16.6 M | -21.6 M | -21 M | -10.4 M | -27.1 M | -17.4 M | -12 M | -17.4 M | -13 M | -12.5 M | -12.2 M | -12 M | -18.2 M | -6.18 M | -12.1 M | -3.71 M | -4.59 M | -4.71 M | -7.37 M | -9.8 M | -7.83 M | -10.7 M | -8.86 M | -8.66 M | -5.94 M | -6.46 M | -6.56 M | -6.72 M | -3.36 M | -3.73 M | -22.5 M |
Revenue |
15 M | 16 M | - | 17.6 M | 16.4 M | 13.1 M | - | 14.6 M | 14.9 M | 13 M | - | 34.8 M | 17.4 M | 12.4 M | - | 16.5 M | 18.9 M | 23.9 M | - | 21.1 M | 17.8 M | 11.6 M | - | 9.48 M | 9.46 M | 12.9 M | - | 9.77 M | 9.25 M | 6.48 M | 8.99 M | 5.17 M | 6.82 M | 5.9 M | 45.3 M | 46.9 M | 50.7 M | 44.7 M | 14.4 M | 975 K | 2.23 M | 660 K | 338 K | 25 K | - | 500 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
4.94 M | 6.22 M | - | 5.76 M | 4.94 M | 4.79 M | - | 4.47 M | 5.73 M | 6 M | - | 6.43 M | 7.77 M | 6.45 M | - | 7.22 M | 7.63 M | 8.2 M | - | 11.2 M | 7.48 M | 3.91 M | - | 3.38 M | 3.12 M | 3.81 M | - | 2.7 M | 2.39 M | 1.88 M | - | 1.41 M | - | 1.47 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 934 K | 1.91 M | - | - | 25 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-36.5 M | -7.74 M | - | -6.81 M | -36.5 M | -22.3 M | - | -22.1 M | -27.8 M | -36.6 M | - | -13.8 M | -50.1 M | -58.9 M | - | -50.7 M | -50.9 M | -47.3 M | - | -49.9 M | -42.9 M | -30 M | - | -23 M | -25.4 M | -21.5 M | - | -22.5 M | -25.3 M | -32.6 M | -41.2 M | -28.2 M | -25.4 M | -34.2 M | -30.6 M | -31.8 M | -25.5 M | -19.1 M | -32.2 M | -17.2 M | -17 M | -15.6 M | -13 M | -18.1 M | -7.76 M | -12.6 M | -4.96 M | -4.35 M | -4.76 M | -6.58 M | -9.52 M | -7.5 M | -10.3 M | -8.46 M | -8.3 M | -5.83 M | -6.46 M | -6.58 M | -5.23 M | -3.53 M | -3.74 M | -22.5 M |
Interest Expense |
-62 K | 1.04 M | - | 17.7 M | -62 K | -12 K | - | 1.07 M | 282 K | -21 K | - | 620 K | 395 K | 304 K | - | 648 K | - | - | - | - | - | - | - | 6.96 M | 3.06 M | 3.12 M | - | 3.17 M | 3.11 M | 2.47 M | - | 2.23 M | 2.14 M | 2.08 M | - | 3.22 M | 1.38 M | 698 K | - | 689 K | 529 K | 620 K | - | 350 K | 352 K | 331 K | - | 121 K | 119 K | 966 K | - | 493 K | 485 K | 476 K | - | 183 K | 19 K | 19 K | - | 19 K | 19 K | 17 K |
EBITDA |
-35.4 M | -7.65 M | - | -6.71 M | -36.4 M | -22.2 M | - | -22 M | -27.4 M | -36.2 M | - | -13.4 M | -49.3 M | -58 M | - | -49.9 M | -50.1 M | -46.5 M | - | -49.2 M | -42.3 M | -29.4 M | - | -22.4 M | -24.8 M | -21 M | - | -22 M | -24.8 M | -32.1 M | -41.2 M | -27.8 M | -25.1 M | -34 M | -30.6 M | -31.6 M | -25.3 M | -18.4 M | -31.7 M | -17 M | -17 M | -15.6 M | -13 M | -18.1 M | -7.75 M | -12.6 M | -4.96 M | -4.33 M | -4.75 M | -6.58 M | -9.52 M | -7.49 M | -10.3 M | -8.46 M | -8.3 M | -5.83 M | -6.46 M | -6.58 M | -5.23 M | -3.51 M | -3.73 M | -22.5 M |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 34.5 M | 39.1 M | - | 88.6 M | 32.2 M | 40.1 M | - | 79.5 M | 73.9 M | 62.3 M | - | 17.2 M | 17.4 M | 15.8 M | - | 18.1 M | 7.76 M | 12.6 M | - | 4.35 M | 4.76 M | 6.58 M | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
38.8 M | 15.9 M | - | 17.4 M | 38.8 M | 25.7 M | - | 22 M | 20.8 M | 17.9 M | - | 21.7 M | 24.4 M | 25.3 M | - | 30.1 M | 29 M | 26.3 M | - | 22.2 M | 19.4 M | 12.5 M | - | 15.4 M | 11.1 M | 10.8 M | - | 14.3 M | 13.4 M | 13.5 M | - | 12.2 M | 13.1 M | 13.5 M | - | 12.3 M | 8.52 M | 7.98 M | - | 7.62 M | 6.64 M | 7.93 M | - | 7.13 M | 3.8 M | 3.49 M | - | 2.74 M | 2.39 M | 2.1 M | - | 2.14 M | 2.5 M | 2.48 M | - | 2.05 M | 1.94 M | 2 M | - | 1.78 M | 1.59 M | 593 K |
Quarterly performance
Select metrics to display
All numbers in USD currency
The income statement is one of the three key financial reports of a company Fortress Biotech (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
USA
Schweiz
Canada
Germany
Niderland
China
Israel
